Yoshihito Uchida

19PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersChinese languagesGastroenterology and hepatologyTraditional Chinese medicine and treatmentsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 06, 2026
Rifaximin Use Is Associated With Prognosis and Recurrence Patterns in Spontaneous Bacterial Peritonitis: Exploratory Insights Into the Oral-Gut-Hepatic Axis.

Yoshihito Uchida, Naoto Soma, Shunsuke Yamada

|Mar 28, 2026
Reply to the letter by Liu and Jia.

Yoshihito Uchida, Satoshi Mochida

|Feb 09, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

Takanori Suzuki, Kentaro Matsuura, Yuki Tahata

|Sep 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination.

Yuta Myojin, Hayato Hikita, Yuki Tahata

|May 03, 2025
Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021.

Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida

|Mar 06, 2025
Endoscopic management of primary sclerosing cholangitis.

Suguru Mizuno, Yoshihito Uchida, Satsuki Ando

Pageof 4

Frequent Collaborators

8 joint publications

Masamitsu Nakao

5 joint publications

Nobuaki Nakayama

5 joint publications

Taro Takami

2 joint publications

Tetsuo Takehara